During the past decade, Harris Health System conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harris Health System" #1 sponsor was "Baylor College of Medicine" with 2 trials, followed by "M.D. Anderson Cancer Center" with 2 trials sponsored, "Andrew Dinardo" with 1 trials sponsored, "Baylor Breast Care Center" with 1 trials sponsored and "Kaiser Permanente" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harris Health System" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Baylor College of Medicine" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cancer Therapy and Research Center, Texas" with 1 trials as a collaborator and "Cedars-Sinai Medical Center" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Harris Health System" are "Bladder Cancer" (1 trials), "Breast Cancer Stage IV" (1 trials), "Cervical Cancer" (1 trials), "Colorectal Neoplasms" (1 trials) and "Coronavirus" (1 trials). Many other conditions were trialed in "Harris Health System" in a lesser frequency.

Most popular intervention types in "Harris Health System" are "Drug" (5 trials), "Behavioral" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine Injection" (1 trials), "BCG Vaccine" (1 trials), "Binimetinib" (1 trials), "CRCS patient decision aid (PtDA) video" (1 trials) and "Encorafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Harris Health System" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Harris Health System". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Harris Health System, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Harris Health System, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".